| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 1994 | 2020 | ||||||||
|
acrosin | 0.493 | 0.846 | 1.2E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2018 | ||||||||
|
activating transcription factor 5 | 0.674 | 0.385 | 0.29 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 18 | 0.636 | 0.654 | 1.1E-29 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
adaptor related protein complex 5 subunit zeta 1 | 0.700 | 0.346 | 7.3E-31 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
alkaline phosphatase, placental | 0.487 | 0.808 | 1.8E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
alpha hemoglobin stabilizing protein | 0.700 | 0.385 | 3.3E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1996 | 1997 | ||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
asparaginase and isoaspartyl peptidase 1 | 0.494 | 0.808 | 2.8E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2018 | ||||||||
|
attractin like 1 | 0.546 | 0.769 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
autocrine motility factor receptor | 0.599 | 0.692 | 5.8E-05 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
autophagy related 7 | 0.505 | 0.769 | 7.4E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
BAF chromatin remodeling complex subunit BCL11B | 0.568 | 0.731 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1995 | 2018 |